EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Multicenter study of patients with transthyretin cardiac amyloidosis in Poland: Clinical characteristics, genotyping, electrocardiographic features, outcome predictors, and tafamidis treatment outcomes

Monika Gawor-Prokopczyk, Jacek Grzybowski, Marta Lipowska, Grażyna Truszkowska, Joanna Ponińska, Renata Rajtar-Salwa, Michał Susuł, Daria Keller, Ewa Straburzyńska-Migaj, Alicja Dąbrowska-Kugacka, Łukasz Mazurkiewicz

Polish Heart Journal · 2026

DOI: 10.33963/v.phj.109824 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Polish Heart Journal, 2026. Verfasst von Monika Gawor-Prokopczyk und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiomyopathy, National Institute of Cardiology, Warszawa, Poland. mgawor@ikard.pl. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Benzoxazoles, Cardiomyopathies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: We present the first multicenter, non-interventional, longitudinal observational study of patients diagnosed with cardiac transthyretin amyloidosis (ATTR-CA) in Poland. AIMS: The aim of this study was to describe the clinical characteristics, survival rates, and treatment outcomes of patients with ATTR-CA in Poland, and to identify potential markers linked to an increased risk of disease progression. METHODS: Between 2017 and 2025, consecutive patients with confirmed ATTR-CA were evaluated at 4 cardiology centers. Assessments included blood tests, standard 12-lead electrocardiography, and transthoracic echocardiography. The primary endpoint was defined as death or heart transplantation. RESULTS: ATTR-CA was confirmed in 115 patients, including 21 (18.2%) with hereditary disease. The median follow-up was 24 (12-41) months for the entire cohort and 25 (14.2-46.7) months for surviving patients (n = 78). The primary endpoint occurred in 37 (32.2%) patients. In multivariable analysis, the ratio of the transmitral early peak velocity (E) estimated by pulsed wave Doppler over the early mitral annulus velocity (e'), body mass index, and levels of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide were independent predictors of the primary endpoint. Tafamidis was received by 81 (70.4%) patients and was associated with significantly lower risk of the primary endpoint (P = 0.005), stroke, or transient ischemic attack (P = 0.047), and a markedly longer median survival (84 months [95% confidence interval, 68-116] vs. 14 months [95% confidence interval, 7-36]; log-rank P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialBenzoxazolesCardiomyopathiesHumansFemaleMalePolandElectrocardiographyAgedMiddle AgedTreatment OutcomeLongitudinal StudiesGenotypeEchocardiographyPeptide FragmentsNatriuretic Peptide, Brain

Stichwörter der Autor:innen

ATTRcardiac amyloidosistafamidistransthyretin amyloidosis

Substanzen

tafamidisBenzoxazolesPeptide Fragmentspro-brain natriuretic peptide (1-76)Natriuretic Peptide, Brain

Autor:innen und Institutionen

  • Department of Cardiomyopathy, National Institute of Cardiology, Warszawa, Poland. mgawor@ikard.pl.
  • Department of Cardiomyopathy, National Institute of Cardiology, Warszawa, Poland.
  • Department of Neurology, Medical University of Warsaw, Warszawa, Poland.
  • European Reference Network On Rare Neuromuscular Diseases (ERN EURO-NMD).
  • Department of Medical Biology, Molecular Biology Laboratory, National Institute of Cardiology, Warszawa, Poland.
  • Clinical Department of Cardiology and Cardiovascular Interventions, University Hospital, Kraków, Poland.

Zitieren

APA

Gawor-Prokopczyk, M., Grzybowski, J., Lipowska, M., Truszkowska, G., Ponińska, J., Rajtar-Salwa, R., Susuł, M., Keller, D., Straburzyńska-Migaj, E., Dąbrowska-Kugacka, A., & Mazurkiewicz, Ł. (2026). Multicenter study of patients with transthyretin cardiac amyloidosis in Poland: Clinical characteristics, genotyping, electrocardiographic features, outcome predictors, and tafamidis treatment outcomes. Polish Heart Journal. https://doi.org/10.33963/v.phj.109824

Vancouver

Gawor-Prokopczyk M, Grzybowski J, Lipowska M, Truszkowska G, Ponińska J, Rajtar-Salwa R, et al. Multicenter study of patients with transthyretin cardiac amyloidosis in Poland: Clinical characteristics, genotyping, electrocardiographic features, outcome predictors, and tafamidis treatment outcomes. Polish Heart Journal. 2026. doi:10.33963/v.phj.109824

BibTeX
@article{GaworProkopczyk2026,
  author = {Gawor-Prokopczyk, Monika and Grzybowski, Jacek and Lipowska, Marta and Truszkowska, Grażyna and Ponińska, Joanna and Rajtar-Salwa, Renata and Susuł, Michał and Keller, Daria and Straburzyńska-Migaj, Ewa and Dąbrowska-Kugacka, Alicja and Mazurkiewicz, Łukasz},
  title = {Multicenter study of patients with transthyretin cardiac amyloidosis in Poland: Clinical characteristics, genotyping, electrocardiographic features, outcome predictors, and tafamidis treatment outcomes},
  journal = {Polish Heart Journal},
  year = {2026},
  doi = {10.33963/v.phj.109824}
}
Kostenlos starten →